loading...
Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Published in 2018
ABC Dementia Scale Study Group
Alzheimer Disease
Kikuchi T, Mori T, Wada-Isoe J, Umeda-Kameyama Y, Kagimura T, Kojima S, Akishita M, Nakamura Y. A Novel Dementia Scale for Alzheimer’s Disease . J Alzheimers Dis Parkinsonism. 2018; 8(2):1-7. (Full text article)
Mori T, Kikuchi T, Umeda-Kameyama Y, Wada-Isoe K, Kojima S, Kagimura T, Kudoh C, Uchikado H, Ueki A, Yamashita M, Watabe T, Nishimura C, Tsuno N, Ueda T,Akishita M, Nakamura Y; ABC Dementia Scale Study Group. ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer's Disease Severity. Dement Geriatr Cogn Dis Extra. 2018 Mar 14;8(1):85-97. (Full text article)
ABC Dementia Scale Study Group
Corresponding author:
Takashi Kikuchi
Foundation for Biomedical Research and Innovation
Email: abc_scale@tri-kobe.org
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
If the users of ABC-DS want to use the patented evaluation algorithm or the Three Dimensional distance (TDD) in a commercial clinical trial or a funded academic research, another fee will be charged.For details, please contact to Dr. Takashi Kikuchi.
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.
Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
Access to advanced descriptions of Clinical Outcome Assessments (COAs)